Cargando…

Initiating insulin: How to help people with type 2 diabetes start and continue insulin successfully

Detalles Bibliográficos
Autores principales:	Polonsky, William H., Arsenault, Joyce, Fisher, Lawrence, Kushner, Pamela, Miller, Eden M., Pearson, Teresa L., Tracz, Mariusz, Harris, Stewart, Hermanns, Norbert, Scholz, Bernd‐M., Pollom, Robyn K., Perez‐Nieves, Magaly, Pollom, Roy Daniel, Hadjiyianni, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601201/ https://www.ncbi.nlm.nih.gov/pubmed/28735508 http://dx.doi.org/10.1111/ijcp.12973

Ejemplares similares

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
por: Kalirai, Samaneh, et al.
Publicado: (2020)

Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
por: Hadjiyianni, I., et al.
Publicado: (2016)

Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis
por: Stuckey, Heather, et al.
Publicado: (2019)

Lilly Insulin Glargine Versus Lantus(®) in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5)
por: Pollom, Robyn K., et al.
Publicado: (2019)

Clinical Outcomes of Patients with Diabetes Who Exhibit Upper-Quartile Insulin Antibody Responses After Treatment with LY2963016 or Lantus(®) Insulin Glargine
por: Ilag, Liza L., et al.
Publicado: (2017)

Key Strategies for Overcoming Psychological Insulin Resistance in Adults with Type 2 Diabetes: The UK Subgroup in the EMOTION Study
por: Balogh, Elemer G., et al.
Publicado: (2020)

Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation: A Retrospective Database Study Among People with Type 2 Diabetes Mellitus in Japan
por: Hadjiyianni, Irene, et al.
Publicado: (2016)

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus
por: Ilag, L. L., et al.
Publicado: (2016)

Treatment Patterns and Outcomes Before and After Humulin R U-500 Initiation Among US Patients with Type 2 Diabetes Previously Prescribed ≤ 200 Units/day of U-100 Insulin
por: Chen, Jieling, et al.
Publicado: (2022)

Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes
por: Okazaki, Kentaro, et al.
Publicado: (2019)

Starting insulin in type 2 diabetes: Overcoming barriers to insulin therapy
por: Kabadi, Udaya M.
Publicado: (2008)

Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study
por: Hermanns, Norbert, et al.
Publicado: (2010)

Barriers to Insulin Initiation: The Translating Research Into Action for Diabetes Insulin Starts Project
por: Karter, Andrew J., et al.
Publicado: (2010)

Size-Based Hydroacoustic Measures of Within-Season Fish Abundance in a Boreal Freshwater Ecosystem
por: Pollom, Riley A., et al.
Publicado: (2015)

Editorial: Atypical and malignant meningioma: Advances in pathophysiology, imaging and treatment
por: Ahmad, Maleeha, et al.
Publicado: (2022)

Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With Cancer
por: Taparra, Kekoa, et al.
Publicado: (2022)

Trajectory of Glycated Hemoglobin Over Time Among Obese Type 2 Diabetes Patients on U-100 Basal-Bolus Insulin Regimen Using Real-World Data
por: Chen, Jieling, et al.
Publicado: (2021)

Where Does Insulin Resistance Start?: The brain
por: Pagotto, Uberto
Publicado: (2009)

Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trials
por: Cummings, M. H., et al.
Publicado: (2018)

Similar Efficacy and Safety of Basaglar(®) and Lantus(®) in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study
por: Pollom, Robyn K., et al.
Publicado: (2018)

In Regard to Odei et al.
por: Kahn, Jenna M., et al.
Publicado: (2021)

Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
por: Ascher-Svanum, Haya, et al.
Publicado: (2014)

Determining starting basal rates of insulin infusion for insulin pump users: a comparison between methods
por: Chow, Nelson, et al.
Publicado: (2016)

False News of a Cannabis Cancer Cure
por: Shi, Siyu, et al.
Publicado: (2019)

Insulin-like growth factor-1 signaling in renal cell carcinoma
por: Tracz, Adam F., et al.
Publicado: (2016)

Adherence to Basal Insulin Therapy Among People with Type 2 Diabetes: A Retrospective Cohort Study of Costs and Patient Outcomes
por: Perez-Nieves, Magaly, et al.
Publicado: (2018)

Impact of mental illness on end‐of‐life emergency department use in elderly patients with gastrointestinal malignancies
por: Kashyap, Mehr, et al.
Publicado: (2021)

Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire)
por: Messina, Rossella, et al.
Publicado: (2023)

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study
por: Gordon, J, et al.
Publicado: (2010)

Barriers of Doctors and Patients in Starting Insulin for Type 2 Diabetes Mellitus
por: Alidrisi, Haider A, et al.
Publicado: (2021)

Efficacy and safety of ultra‐rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO‐Peds trial
por: Wadwa, R. Paul, et al.
Publicado: (2022)

Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire)
por: Messina, Rossella, et al.
Publicado: (2023)

Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy
por: Matza, Louis S., et al.
Publicado: (2019)

Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review
por: Rahimy, Elham, et al.
Publicado: (2020)

Reversible insulin resistance helps Bactrian camels survive fasting
por: Guo, Fucheng, et al.
Publicado: (2021)

Real-World Patterns of Basal Insulin Use with Other Diabetes Medications Among People with Type 2 Diabetes Between 2014 and 2020
por: Schapiro, David, et al.
Publicado: (2023)

Palliative Care Service Utilization and Advance Care Planning for Adult Glioblastoma Patients: A Systematic Review
por: Wu, Adela, et al.
Publicado: (2021)

Potential Formula for the Calculation of Starting and Incremental Insulin Glargine Doses: ALOHA Subanalysis
por: Kadowaki, Takashi, et al.
Publicado: (2012)

Is the Indicator Magnifying Window for Insulin Pens Helpful for Elderly Diabetic Patients?
por: Lee, Ju Hee, et al.
Publicado: (2013)

The clinical and financial cost of mental disorders among elderly patients with gastrointestinal malignancies
por: Harris, Jeremy P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_22eoeql0kbaqnlb8jvug04vqo5